L. Orö
-
- Cardiac pacing and defibrillation studies 3
- Cardiac electrophysiology and arrhythmias 3
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 3
- Biochemistry top 10%
-
- Lipoproteins and Cardiovascular Health 5
- Hemodynamic Monitoring and Therapy 3
-
- Pharmacology and Obesity Treatment 3
-
- Electrical and Bioimpedance Tomography 3
-
- Peroxisome Proliferator-Activated Receptors 3
L. Orö
25 papers receiving 626 citations
Peers
Comparison fields: 5 of 82
- Cardiology and Cardiovascular Medicine 309
- Endocrinology, Diabetes and Metabolism 133
- Biochemistry 44
- Surgery 229
- Pharmacology 84
Countries citing papers authored by L. Orö
This map shows the geographic impact of L. Orö's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Orö with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Orö more than expected).
Fields of papers citing papers by L. Orö
This network shows the impact of papers produced by L. Orö. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Orö. The network helps show where L. Orö may publish in the future.
Co-authorship network
The 25 scholars most cited alongside L. Orö, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 1981 | 46 | |
| 3 | Treatment of angina pectoris with metoprolol. A comparison between Durules administered once daily and tablets administered twice daily. | 1981 | 2 |
| 4 | 1980 | 6 | |
| 5 | 1979 | 86 | |
| 6 | 1976 | 25 | |
| 7 | Cholestyramine, clofibrate and nicotinic acid as single or combined treatment of type IIa and IIb hyperlipoproteinaemia. | 1975 | 39 |
| 8 | 1975 | 105 | |
| 9 | 1972 | 14 | |
| 10 | 1972 | 20 | |
| 11 | 1971 | 52 | |
| 12 | 1970 | 21 | |
| 13 | 1968 | 57 | |
| 14 | 1967 | 17 | |
| 15 | 1967 | 10 | |
| 16 | 1967 | 14 | |
| 17 | 1965 | 22 | |
| 18 | 1965 | 24 | |
| 19 | 1965 | 11 | |
| 20 | 1963 | 6 |
About L. Orö
L. Orö is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Biochemistry, having authored 25 papers that have together received 730 indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (5 papers), Cardiac pacing and defibrillation studies (3 papers), Pharmacology and Obesity Treatment (3 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers), Electrical and Bioimpedance Tomography (3 papers), Peroxisome Proliferator-Activated Receptors (3 papers), Cardiac electrophysiology and arrhythmias (3 papers) and Hemodynamic Monitoring and Therapy (3 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (309 citations), Endocrinology, Diabetes and Metabolism (133 citations) and Biochemistry (44 citations). L. Orö has collaborated with scholars based in Sweden, Sri Lanka and Germany. Frequent co-authors include Lars A. Carlson, L G Ekelund, Stephan Rössner, Sture Bevegård, A G Olsson, Jan Östman, Jan‐Henrik Atterhög, Anders Olsson, Bo Jönsson and O Edhag. Their work appears in journals such as Atherosclerosis, Scandinavian Journal of Clinical and Laboratory Investigation, Heart, Clinical Cardiology and Life Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.